CDX2 and carcinoma: (4) SATB2 loss occurs much more frequently than loss of CDX2, with a substantial portion of SATB2-negative CRCs showing a diffuse or at least heterogeneous CDX2 positivity, generally delineating CDX2 as the more sensitive marker of colorectal differentiation in carcinomas.